1 / 12

IKGDAR 100MG INJECTION | Rituximab | Apple pharmaceuticals

IKGDAR 100MG INJECTION (Rituximab) is an anticancer medicine which is used in the treatment of non-hodgkin lymphoma (nhl), blood cancer (chronic lymphocytic leukemia), rheumatoid arthritis etc @ myapplepharma

jacquline
Télécharger la présentation

IKGDAR 100MG INJECTION | Rituximab | Apple pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IKGDAR 100MG INJECTION | Rituximab | Apple pharmaceuticals

  2. Ikgdar 100mg • Ikgdar 100mg is a anticancer medicine which prevents the growth and spread of cancer cells in the body. • The main ingredient which is used as rituximab. • Ikgdar 100mg will help to prevent the Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment.

  3. INDICATION • Ikgdar 100mg and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC).  • Ikgdar100mg injection combination with methotrexate (Otrexup, Rasuvo, Xatmep, others) is also indicated for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of regimen knowns as tumor necrosis factor (TNF) inhibitor. 

  4. BEFORE EACH INFUSION THE DRUG IS PREMEDICATE :  First infusion: • Starting treatment rate of 50 mg/hr is administer , in not showing infusion toxicity, rate raised up to 50 mg/hr increments at intervals of 30 min and max of 400 mg/hr. Successive infusion: • initial at rate of 100 mg/hr, in not showing infusion toxicity, rate raised upto 100 mg/hr increments at intervals of 30 min and max of 400 mg/hr.

  5. LOW GRADE OR FOLLICULAR NON-HODGKINS LYMPHOMA: • The drug Dose is 375 mg/m2 as an IV infusion. • Once weeks for 4 or 8 doses administrated for Relapsed treatment Once weekly for 4 doses administrated for Retreatment for relapsed. • Previously untreated: administer on day 1 of each cycle of chemotherapy, up to 8 doses.

  6. Ikgdar 100mg

  7. ADMINISTRTION • Take an amount Ikgdar injection is administer and diluted to final concentration of 1 mg/ml upto 4 mg/ml as infusion (containing either 0.9% Nacl or 5% dextrose in water). • Gently Invert the bag and mix the solution. • Discard unused drug left in vial. 

  8. DOSAGE • The dose 250 mg/m2 of Ikgdar injection within 4 hours prior to the administration of Indium-111-(In-111-) Zevalin and Yttrium-90- (Y-90-) Zevalin. 7–9 days before to Rituxan and Y-90- Zevalin administrate Rituxan and In-111-Zevalin. • When combination of Ikgdar injection with methotrexate is administrated. Ikgdar injection given as two dose of 100mg IV infusion 2 weeks separated.

  9. IKGDAR 100MG INJECTION

  10. SIDE EFFECTS Common effects: • fever and chills (flu liksymptoms) Less common side effects:Weakness; • nausea ; • headache; • cough ; • dyspnea ; • pharyngitis

  11. CONTACT Phone Number +91-9987711567 URL https://myapplepharma.com/ikgdar-100mg.php Email ID applepharmaceutical@gmail.com info@myapplepharma.com

  12. THANKS FOR WATCHING

More Related